This inventor holds 1 USPTO granted patent. Top assignees: Humanwell Pharmaceutical US, Yichang Humanwell Pharmaceutical Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Xueming Wu: Innovator in Pharmaceutical Formulations
Introduction
Xueming Wu is a notable inventor based in Ballwin, MO (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in pain management. His innovative work focuses on the development of new formulations that enhance the delivery and efficacy of analgesic drugs.
Latest Patents
Xueming Wu holds a patent for "Pharmaceutical formulations containing Nalbuphine." This patent describes new pharmaceutical formulations, their preparation, and their use for pain treatment. Specifically, it details formulations of the analgesic drug Nalbuphine designed for intranasal administration. This advancement has the potential to improve pain management strategies for patients.
Career Highlights
Throughout his career, Xueming Wu has worked with prominent companies in the pharmaceutical industry. He has been associated with Humanwell Pharmaceutical US and Yichang Humanwell Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Xueming Wu has collaborated with several professionals in his field, including Renhe Qiu and Hong Du. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical formulations.
Conclusion
Xueming Wu is a distinguished inventor whose work in pharmaceutical formulations, particularly with Nalbuphine, showcases his commitment to improving pain treatment options. His contributions to the field are noteworthy and reflect his dedication to innovation in healthcare.